Case Study: Medozai

Background

Medozai was founded by Sohaib Rumi after more than a decade working across pharmacy, clinical environments, and healthcare operations.

Throughout his career, Sohaib saw firsthand how much of the patient journey relies on manual processes and administrative work. Clinics were spending significant time coordinating intake, scheduling, documentation, follow-ups, and other operational tasks that pulled attention away from patient care.

Medozai was created to help solve that problem; an AI-powered platform that automates key clinical and administrative workflows, helping healthcare teams operate more efficiently while improving the patient experience.

Joining the Growth Program

Medozai joined the GB Accelerator's Growth Program with a clear goal: build a fundable business plan that could support the company's next stage of growth. At the time, the company had a working product, active customer conversations, and a growing vision for how AI could support healthcare providers. The challenge wasn't a lack of opportunity but deciding where to focus.

The platform had applications across a wide range of healthcare settings, but the company needed clarity around its ideal customer profile, pricing model, go-to-market strategy, fundraising approach, and product roadmap. At the same time, Sohaib was navigating the complexities of healthcare technology, including EMR integrations and understanding how purchasing decisions are made within clinics and hospitals.

The GBA intentionally assembles selection committees with experience relevant to each business and market opportunity. This approach helps ensure companies are evaluated by individuals who understand both the challenges and potential within their industry.

For Medozai, the selection committee included Daniel Shaw, a GBA board member and startup operator with experience across three successful exits, Brad Riddoch, a marketing strategist with extensive experience in positioning and go-to-market execution, and Rebecca Brookham, a healthcare innovation leader with deep experience working within Ontario's healthcare system.

The committee recognized the potential of Medozai's vision to reduce administrative burden in healthcare through AI, while also identifying opportunities to strengthen the company's market positioning, customer focus, and commercialization strategy. The breadth of expertise represented within the committee, combined with the wider GBA mentor network, positioned the program to provide support across healthcare, fundraising, product strategy, and go-to-market execution.

Challenges

One of the first challenges identified during the program was focus. Like many early-stage companies, Medozai had built a solution that could serve a wide range of healthcare providers. While this created opportunity, it also made it difficult to clearly communicate who the product was for and where the company should concentrate its efforts first.

Through ongoing mentor sessions, Sohaib refined the ideal customer profile, narrowed Medozai’s target market, and developed a more structured sales process. The team worked through questions around pricing, onboarding, customer acquisition, and how to position the platform within a healthcare environment that is often resistant to new technology.

The program also helped Medozai rethink how it communicated its value. Rather than leading with AI features and technical capabilities, the company shifted its messaging toward outcomes that matter to clinics. This work led to a complete refresh of the company's website, sales materials, and outreach strategy.

Another area of focus was product development. Discussions with mentors and healthcare stakeholders helped the team better understand how clinics and hospitals evaluate new technology. 

Alongside product and market strategy, the program supported Medozai's fundraising efforts and long-term business planning. The company refined its business model, explored government funding opportunities, strengthened its capital strategy, and expanded its network of investors, healthcare organizations, and innovation partners.

“We've been part of many accelerators. Honestly, none of them gave us what GBA did. What we were missing everywhere else was simple: active advisors. Real involvement from mentors. Not check-ins. Not light touches. Actual engagement. GBA filled that gap.”

- Sohaib Rumi

Results and Achievements:

Over the four-month Growth Program, Medozai made meaningful progress across fundraising, customer validation, product development, and healthcare partnerships.

Since completing the program, the company has:

  • Been selected into the NVIDIA Inception Program

  • Completed integrations with the two largest EMRs and is now expanding to others

  • Nearly doubled monthly recurring revenue

  • Secured $150,000 in funding with an additional $100,000 committed

  • Built a triage system with regional hospital practitioners that could help reduce ER crowding

  • Partnered with universities in the region to research existing solutions and AI adoption in clinical settings

  • Grown its network of accelerator, research, and ecosystem partners

  • Refined pricing into a structured tiered model

  • Rebuilt its website, messaging, and sales process around a clearly defined customer profile, including a shift to nurse practitioner led clinics

  • Expanded product capabilities from voice and chat agents to a broader AI powered practice management platform

  • Refined the product to match clinical workflows with the help of GBA mentors and partners

“When we walked in, our UI was basic. We were still exploring which problem we were really solving, how we were positioned, what we were selling. We were busy building features instead of focusing on what we already had and how it would benefit clients.” - Sohaib Rumi

Conclusion:

Medozai's experience in the Growth Program highlights the value of active, invested advisors who become part of a founder's decision-making process. Rather than providing occasional feedback, the mentor team worked alongside the company to challenge assumptions, refine strategy, and help navigate critical decisions around product, fundraising, and growth.

This case study highlights how targeted mentorship and strategic support can help early-stage companies translate momentum into sustainable, long-term growth.


Learn more about our programs here.

Next
Next

Case Study: The Barking Brew